Dignitana AB today publishes the September 2018 edition of the company newsletter, attached to this release.
The Dignitana IN BRIEF newsletter is published monthly for Dignitana shareholders. It is posted to the Dignitana website athttp://www.dignitana.se/newsletter/ and is available by email subscription at http://eepurl.com/dwHiLf
Lund, Sweden - 7 September 2018
Melissa Bourestom Phone: +1 469 518 5031 Email: firstname.lastname@example.org
About Dignitana AB (publ)
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser. Learn more at www.dignitana.se and www.dignicap.com.
Dignitana AB, world leader in clinically superior scalp cooling technology, today publishes the May 2018 edition of the company newsletter. This edition features updates on company growth in Europe, product availability in the U.S., the Annual General Meeting, and U.S. insurance coverage.
Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.
10925 Estate Lane, Suite 185
Dallas, TX 75238
226 60 Lund, Sweden
+46 46 16 30 90